Smart Biotech Management For Clinical Trial Paths
By Brian Ganch:The administering of clinical trials in the biopharmaceutical industry can be an extremely lengthy, pricey, and resource-intensive process for the organizations participating, especially for the smaller start-up firms. In order to commercially penetrate the markets of other nations, a drug must first be approved by the regulatory bodies of those nations, a process which often involves more clinical trials. This has sent top management of some firms looking for creative ways to reduce expenses and pressure on their organizations while guiding their product through the clinical process in multiple countries. One idea is to forge negotiations and agreements with the various regulatory agencies, health organizations, and GMP contractors in order to share clinical trial data, manufacturer products, and other information. Sharing this data would result in fewer trials, faster commercialization time and significantly less expense. It is the smart and resourceful CEO that attempts this path in an effort toComplete Story »
- Original article
- Login or register to post comments
